Northpointe Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,552,740
| Closed | -$15M | – | 192 |
|
|
2017
Q3 | $15M | Buy |
1,552,740
+304,232
| +24% | +$2.93M | 1.6% | 9 |
|
|
2017
Q2 | $14.8M | Buy |
1,248,508
+171,312
| +16% | +$2.03M | 1.55% | 6 |
|
|
2017
Q1 | $13.8M | Buy |
1,077,196
+217,847
| +25% | +$2.79M | 1.51% | 7 |
|
|
2016
Q4 | $10.5M | Sell |
859,349
-538,939
| -39% | -$6.6M | 1.05% | 30 |
|
|
2016
Q3 | $16.5M | Sell |
1,398,288
-114,446
| -8% | -$1.35M | 1.71% | 6 |
|
|
2016
Q2 | $13.2M | Buy |
1,512,734
+510,472
| +51% | +$4.44M | 1.56% | 10 |
|
|
2016
Q1 | $5.28M | Sell |
1,002,262
-214,219
| -18% | -$1.13M | 0.66% | 50 |
|
|
2015
Q4 | $9.57M | Hold |
1,216,481
| – | – | 1.26% | 16 |
|
|
2015
Q3 | $9.57M | Buy |
+1,216,481
| New | +$9.57M | 1.25% | 16 |
|